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ER stress and UPR activation in glioblastoma:
identiﬁcation of a noncanonical PERK mechanism
regulating GBM stem cells through SOX2
modulation
Natalia M. Peñaranda-Fajardo1, Coby Meijer1, Yuanke Liang1, Bianca M. Dijkstra2, Raul Aguirre-Gamboa 3,
Wilfred F. A. den Dunnen4 and Frank A. E. Kruyt1
Abstract
Patients with aggressive brain tumors, named glioblastoma multiforme (GBM), have a poor prognoses. Here we
explored if the ER stress/unfolded protein response (UPR) is involved in the pathophysiology of GBM and may provide
novel therapeutic targets. Immunohistochemical analyses of a tissue microarray containing primary GBM specimens
showed strong variability in expression of the UPR markers GRP78/BiP, XBP1, and ATF4. Interestingly, high ATF4
expression was associated with poor overall survival suggesting involvement of PERK signaling in GBM progression. In
vitro experiments using patient-derived neurospheres, enriched for GBM stem cells (GSCs), showed high sensitivity for
the ER stressor thapsigargin (Tg) mainly via PERK signaling. In contrast, neurospheres-derived differentiated GBM cells
were less sensitive likely due to lower UPR activity as indicated by comparative transcriptional proﬁling. Tg and
Tunicamycin strongly reduced neurosphere forming ability of GSCs that was linked with potent PERK-dependent
downregulation of SOX2 protein. Interestingly, SOX2 downregulation occurred directly via PERK, not requiring
downstream activation of the PERK-UPR pathway. Moreover, PERK inactivation resulted in aberrant serum-induced
differentiation of GBM neurospheres accompanied by persistent SOX2 expression, delayed upregulation of GFAP and
reduced cell adherence. In conclusion, we provide evidence that PERK signaling contributes to the prognoses of
primary GBM patients and identiﬁed PERK as a novel regulator of SOX2 expression and GSC differentiation. The role of
PERK appeared to be pleiotropic involving UPR-dependent, as well as novel identiﬁed noncanonical mechanisms
regulating SOX2. ER stress and PERK modulation appear to provide promising therapeutic targets for therapy in GBM.
Introduction
Glioblastoma multiforme (GBM) is the most prevalent
and lethal brain tumor in adults1. Surgery and chemo-
radiotherapy lead to an expected median survival for
newly diagnosed primary GBM of only 12–15 months and
a 5-year survival rate of <5%2. Poor prognosis is caused by
therapy resistance and high inﬁltrative growth of GBM,
making complete resection impossible. Oncogenic driver
mutations have been identiﬁed in GBM that affect reti-
noblastoma, p53 and receptor tyrosine kinase signaling,
but targeting these pathways has not yet resulted in
effective therapy3,4. Transcriptional proﬁling has identi-
ﬁed several subtypes, named proneural (PN), classic, and
mesenchymal (MES) GBM. The PN and MES subtypes
appear most distinct and MES GBM being most aggres-
sive with worst prognosis5. Currently, the isocitrate
dehydrogenase (IDH) gene mutational status and
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methylation status of the MGMT promoter are used as
prognostic markers in GBM6.
GBM tumors are cellular heterogeneous. GBM stem
cells (GSCs) have been identiﬁed that possess self-renewal
and differentiation ability, and are considered drivers of
GBM growth, therapy resistance and relapse of disease7,8.
Novel treatments that effectively target GSCs have been
deemed essential for improving the prognosis of patients.
In the current study we explored if ER stress and the
unfolded protein response (UPR) affect GSCs and may
provide novel targets for therapy.
The UPR is an essential adaptive mechanism that
promotes cell survival under a variety of cell intrinsic
and extrinsic adverse conditions including oncogenesis,
hypoxia, glucose deprivation, and chemotherapy9,10.
These conditions impact the biosynthetic demand and
the correct production of proteins in the ER leading to
UPR activation. The UPR attempts to restore protein
homeostasis by halting protein production, enhancing
protein folding capacity, and increasing protein degra-
dation in order to facilitate cell survival, however,
switches to cell death activation when damage is
overwhelming.
Binding immunoglobulin protein/78 kDa glucose-
regulated protein (BiP/GRP78) is a chaperone in the ER
lumen and a central sensor for ER stress. Upon stress BiP/
GRP78 is released from three ER-transmembrane pro-
teins, RNA-dependent protein kinase-like ER kinase
(PERK), inositol-requiring protein α (IRE1α), and acti-
vating transcription factor 6 (ATF6), leading to the acti-
vation of three distinct but partially functionally
overlapping signaling pathways11. Through dimerization
and auto-phosphorylation PERK activates the eukaryotic
translation initiation factor 2α (eIF2α) leading to
attenuation of global protein translation while speciﬁc
mRNAs are translated, such as activating transcription
factor 4 (ATF4). IRE1α oligomerization and auto-
phosphorylation results in activation of its endor-
ibonuclease activity and subsequent splicing of the X-box
binding protein 1 (XBP1) mRNA yielding the transcrip-
tion factor XBP1s. ATF6 undergoes cleavage in the Golgi
and the ATF6f cleavage product also acts as a transcrip-
tion factor. Subsequently, these transcription factors
orchestrate the UPR including activation of the apoptosis
transcription factor C/EBP-homologous protein (CHOP),
when stress is overwhelming12.
The UPR also plays an important role in cancer and
contributes to resistance to chemotherapeutics13,14.
Notably, the UPR has been linked with reprogramming
gene expression during tumor development and with the
regulation of stem cell properties in both normal and
malignant stem cells15,16. Promising novel therapeutic
strategies have been developed to aggravate pre-existing
(chronic) ER stress conditions in tumor cells by either
increasing ER stress or inhibiting the UPR adaptive sur-
vival responses13,17.
In GBM chronic activation of the UPR has been
reported evidenced by elevated BiP/GRP78 expres-
sion18,19. UPR inhibition was shown to sensitize for
temozolomide, whereas the activity of for example
radiotherapy was dependent on UPR-induced cell
death18,20. Moreover, the UPR has been implicated in
GBM growth and progression although its role in GSC
maintenance remains elusive21.
Here we provide evidence that activation of the PERK
branch of the UPR is involved in GBM prognoses by
immunohistochemical analyses of UPR biomarkers in
primary GBM specimens on a tissue microarray (TMA).
Using GBM patient-derived neurospheres, known to
contain GSCs and representing better the original
tumor22,23, we found that GSCs are highly sensitive for ER
stress. A key role for PERK in regulating ER stress-
dependent self-renewal and differentiation of GSCs was
found involving a novel noncanonical function that reg-
ulates SOX2 protein expression.
Results
BiP/GRP78, XBP1, and ATF4 expression in GBM TMA
A TMA containing specimens from 148 primary GBM
patients (4 cores per patient) was used to examine
expression of BiP/GRP78, ATF4, and XBP1. Main char-
acteristics of patients are summarized in Table 1. BiP/
GRP78 staining was cytoplasmic, ATF4 nuclear and XBP1
was localized both in cytoplasm and nucleus reﬂecting
inactive and active splice variants, respectively (Fig. 1a).
For XBP1 only nuclear staining was scored. Expression
was classiﬁed according to the median staining score in
low and moderate-high expressing groups. BiP/GRP78
was frequently co-expressed with ATF4 with a signiﬁcant
correlation factor of 0.217 and also ATF4 and XBP1
expression were positively correlated with a signiﬁcant
correlation factor of 0.203 (Supplementary Table 1).
Interestingly, low ATF4 expression correlated with pro-
longed overall survival (OS), whereas BiP/GRP78 and
XBP1 expression did not correlate with OS (Fig. 1b).
Table 1 Patient characteristics
Number of primary GBM patients 148
Mean age at surgery in years (range) 61.9 (30.9–84.6)
Number >70 years (%) 29 (19.6)
Male sex (%) 94 (63.5)
Still alive (%) 6 (4.1)
Mean OS in monthsa (range) 13.7 (0.2–57.4)
aOS= overall survival, time between date of surgery and documented date of
death, living patients excluded
Peñaranda-Fajardo et al. Cell Death and Disease          (2019) 10:690 Page 2 of 16
Ofﬁcial journal of the Cell Death Differentiation Association
Together, these ﬁndings suggest a link between the PERK
branch of the UPR and prognosis of GBM patients.
ER stress sensitivity and UPR activation in GBM
neurospheres
To investigate this further, ﬁrst we characterized a panel
of GBM neurospheres for sensitivity to the well-known ER
stress inducer Tg, a sarco/endoplasmic reticulum Ca2+
ATPase (SERCA) inhibitor. A dose-dependent reduction
of cell viability was seen after 24 h treatment that became
more pronounced after 48 h, particularly for MES GG6
and GG16 (Fig. 2a). Similar cytotoxicity proﬁles were seen
upon exposure to another ER stress inducer, tunicamycin
(Tm), although with no clear difference between PN
(GG14 and GSC23) and MES subtypes (Supplementary
Fig. 1A). Preformed GBM GG16 and GSC23 neurospheres
were also sensitive for Tg indicated by sphere disintegra-
tion and increased levels of cellular debris (Fig. 2b).
Tg exposure was accompanied by caspase-3/7 activation
in GG16 and GSC23 cells (Supplementary Fig. 2). The
broad caspase and apoptosis inhibitor Z-VAD partially
suppressed Tg cytotoxicity (Fig. 2c). The involvement of
necroptosis was explored by inhibiting RIPK1 with
necrostatin-1 (Nec-1) and showed also partial protection.
Combined Z-VAD/Nec-1 treatment completely protected
against Tg cytotoxicity after 24 h exposure, although cell
viability decayed at 48 h treatment.
Tg treatment activated the UPR as indicated by strong
induction of BiP/GRP78 in all GBM neurospheres at both a
low (1 µM) and higher dose Tg (IC50) (Fig. 2d). Tg exposure
induced PERK phosphorylation, represented by occurrence
































































Fig. 1 UPR marker expression in primary GBM specimens show correlation between ATF4 levels and overall survival. a Representative
staining patterns of BiP/GRP78, ATF4, and XBP1 protein expression (low, moderate (mod.), and high) in GBM specimen cores on TMA. White scale bar
is 200 µm. Enlarged boxed inserts are also depicted with scale bar of 50 µm. b Kaplan–Meier curves of OS related to the expression of low and
moderate)/high expression of BiP/GRP78, ATF4, and nuclear XBP1. Number of patients in groups is indicated between brackets. Patients with ATF4low
expression had a better prognosis compared with ATF4high; for example, ATF4low correlated with +/−35% OS vs 15% OS ATF4high at 20 months post-
surgery. *p-value < 0.05
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Fig. 2 (See legend on next page.)
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ATF4. IRE1α was also activated reﬂected by increased
XBP1u expression and occurrence of XBP1s. ATF6 was
already detected in untreated neurospheres and accumu-
lated further after treatment. In parallel, concentration-
dependent accumulation of CHOP was observed.
Thus, GBM neurospheres are highly sensitive to Tg,
accompanied by variable activation of all three UPR
branches leading to both apoptosis and necroptosis.
Differentiation of GBM cells reduces thapsigargin
sensitivity
Since tumors are heterogeneous in GSC/non-GSC com-
position we examined Tg sensitivity in serum-differentiated
GBM neurospheres. Differentiated GBM cells were more
resistant to Tg when compared with corresponding neu-
rospheres (Fig. 3a and Table 2). Particularly differentiated
PN GG14 and GSC23 cells appeared resistant also after
prolonged Tg treatment. Analyses of Tg-induced UPR
activation indicated a stronger increase of BiP/GRP78,
CHOP expression and PARP cleavage in GG16 and GSC23
neurospheres compared with differentiated counterparts
(Fig. 3b). UPR branch activation was also seen in differ-
entiated cells, although PERK branch activation appeared
reduced in differentiated GSC23 cells and also p-IRE1α
levels differed in cells (Supplementary Fig. 3A).
To obtain molecular insight in differences in Tg sensi-
tivity RNA sequencing was performed. Comparing tran-
script levels of genes involved in the UPR between
neurospheres and differentiated GG16 and GSC23 cells
revealed clear differences in UPR genes expression patterns
(Supplementary Fig. 3B). Notably, the transcriptional levels
of key players in the three UPR branches were elevated in
neurospheres, including endoplasmic reticulum to nucleus
signaling 1 (ERN1, encoding IRE1α), XBP1, EIF2AK3
(encoding PERK), and ATF6, whereas expression of the
negative regulator of eIF2α, protein phosphatase 1 reg-
ulatory subunit 15A (PPP1R15A, encoding GADD34), was
decreased. Focusing on genes with at least twofold differ-
ence in expression, ﬁve overlapping genes were identiﬁed in
GG16 and GSC23 (Fig. 3c). Neurospheres showed increased
expression of ERN1, insulin-induced gene 1 (INSIG1), and
membrane-bound transcription factor peptidase site 2
(MBTPS2) and decreased expression of SIL1 nucleotide
exchange factor (SIL1) and Nucleobindin 1 (NUCB1).
Overall, these ﬁndings suggest a link between elevated UPR
activity in GBM neurospheres compared with differentiated
cells and higher sensitivity for Tg in neurospheres.
PERK branch mediates ER stress-induced cytotoxicity in
GBM neurospheres
The correlation found between ATF4 expression and
overall patient survival led us to test if the PERK branch is
involved in Tg cytotoxicity by using PERK inhibitor
GSK2606414 (GSK414)17,24. GSK414 strongly reduced
Tg-dependent induction of p-PERK, ATF4 and CHOP in
GG16 and GSC23 cells; optimal inhibition was seen at
1 µM GSK414 since higher concentrations also led to
increases in CHOP expression (Fig. 4a, b). PERK inhibi-
tion resulted in enhanced accumulation of XBP1s, prob-
ably as a compensatory mechanism (Fig. 4b). PERK
inhibition suppressed Tg-induced cytotoxicity that was
associated with decreased cleavage of caspase-3 and PARP
(Fig. 4b, c). Another pharmacological PERK inhibitor,
AMG4425, also effectively blocked PERK activation and
showed similar suppression of Tg cytotoxicity in GG16
(Fig. 4d) and to a lesser extent in GSC23 (Supplementary
Fig. 4). As an alternative approach we tested the effect of
prolonged activation of the PERK branch on Tg cyto-
toxicity by employing the eIF2α phosphatase GADD34
inhibitor Guanabenz (Guana)26. Combined Tg/Guana
treatment resulted in enhanced induction of phosphory-
lated eIF2α as well as CHOP accumulation, although to
variable extents in a cell-dependent way (Supplementary
Fig. 4C), and enhanced Tg cytotoxicity (Fig. 4e and Sup-
plementary Fig. 4D).
The involvement of the other two UPR branches in
mediating ER stress-induced cytotoxicity in the GBM
neurospheres models was also evaluated. However, inhi-
bition of the IRE1α/XBP1 or ATF6 branch by chemical
inhibitors or shRNA-mediated gene silencing, respectively,
did not affect Tg sensitivity (Supplementary Fig. 5A–D).
Overall, these data indicate that the PERK branch mainly
mediates Tg cytotoxicity in GBM neurospheres.
Thapsigargin reduces neurosphere formation ability
accompanied by SOX2 downregulation
According to the CSC hypothesis effective therapy
should target GSCs27. Although GBM neurospheres
(see ﬁgure on previous page)
Fig. 2 GBM neurospheres/GSCs are sensitive for Tg that is accompanied by UPR activation. a GBM Nsp cells were treated with different doses
of Tg for 24 or 48 h. Cell viability was evaluated by MTS assays. Dose and time-dependent cytotoxicity was observed. b Preformed GG16 and GSC23
Nsp were exposed to Tg for 24 h. Phase contrast microscopy (×10) showed strong toxicity as indicated by Nsp disintegration and debris. c MTS assays
of Nsp cells treated with combinations of Tg and the pan-caspase inhibitor Z-VAD, the RIPK1 inhibitor Nec-1 or with the inhibitors combined. Both
apoptosis and necroptosis activation contribute to cytotoxicity. d Western blots showing Tg-induced activation of the UPR by increased BiP/GRP78
and CHOP levels. Tg activated all three UPR branches to varying extents in a cell speciﬁc way as indicated by PERK phosphorylation (upper band) and
ATF4 expression, enhanced expression of XBP1S and ATF6. Error bars indicate standard deviations. *p-value < 0.05
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represent undifferentiated GBM cells it should be noted
that only a proportion of cells have self-renewal potential
that is characteristic for GSCs. To examine the effect of
Tg on self-renewal of GSCs limiting dilution neurosphere
formation assays were performed. Tg resulted in a two- to
fourfold reduction in neurosphere formation ability in
GG6, GG14, and GG16, whereas in GSC23 no signiﬁcant
effects were seen (Fig. 5a). Tm similarly suppressed self-
renewal in GG16 cells, but hardly in GSC23 (Supple-
mentary Fig. 1B).
Next, we examined if Tg affects the expression of SOX2,
a well-known stem cell transcription factor in neuronal
stem cells and GSCs28–30. Interestingly, a robust decrease
in SOX2 protein expression was observed upon 24 h Tg
Fig. 3 Differentiated GBM cells are less sensitive for Tg. a MTS assays showing Tg sensitivity of serum-differentiated neurospheres after 24 and
48 h treatment. Dose and time-dependent cytotoxicity was observed. b Western blots showing time-dependent activation of the UPR by Tg,
represented by expression of BiP/GRP78, CHOP, and PARP cleavage. c RNA-Seq transcript analyses was used to compare the expression of UPR-
related genes in GG16 and GSC23 neurospheres vs. differentiated counterparts. Overall the major UPR branches signals appeared to be higher
expressed in neurospheres (see also Supplementary Fig. 3). Genes that have a Log2 Fold Change >1 an adjusted p-value ≤ 0.05 are depicted
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treatment. SOX2 decrease was particularly strong in
GG16 and GG14 cells, detectable already at low Tg con-
centration (Fig. 5b). Weaker SOX2 downregulation was
seen in GSC23 that may in part explain reduced Tg
sensitivity. Notably, Tg did not affect the expression of
other stem cell transcription factors such as OCT4 and
Olig2 and the stem cell marker Nestin (Fig. 5c).
We proceeded by testing if the PERK branch mediates
SOX2 downregulation. Tg combined with GSK414
potently suppressed SOX2 downregulation in GG16 cells,
whereas inhibition of the IRE1/XBP1 branch did not have
this effect (Fig. 5d, e). Tm also reduced SOX2 expression
that was prevented by GSK414 (Supplementary Fig. 1C).
Thus, ER stress leads speciﬁcally to downregulation of
SOX2 expression via the PERK branch providing a
molecular mechanism for GSC targeting.
PERK regulates ER stress induced SOX2 downregulation
To explore in more detail how the PERK branch reg-
ulates SOX2 expression PERK and ATF4 knockouts were
generated in GG16 cells using CRISPR/CAS9 genomic
editing. Figure 6a, shows effective ablation of the EIF2AK3
gene in GG16-PERK-ko cells indicated by the absence of
PERK protein expression and almost absence of ATF4
induction after Tg exposure and strong reduction of
CHOP accumulation. GG16-ATF4-ko cells showed nor-
mal Tg-induced PERK activation but complete absence of
ATF4 induction illustrating effective ATF4 ablation.
Importantly, SOX2 downregulation was largely suppressed
in GG16-PERK-ko cells, whereas in GG16-ATF4-ko cells
potent SOX2 downregulation was observed similar to
control GG16 cells. SOX2 downregulation occurred at the
protein level since mRNA levels did not change sig-
niﬁcantly in GG16 control and PERK-ko cells (Fig. 6b).
To analyze SOX2 decay at the cellular level immuno-
ﬂuorescence microscopic analyses was performed show-
ing abundant nuclear SOX2 protein expression in the
large majority of GG16 control and GG16-PERK-ko cells.
Tg treatment resulted in a strong general decrease in
SOX2 expression in control cells that was already
detectable 6 h post-treatment, decreasing further after
24 h and some cells showing complete loss of SOX2
expression (Fig. 6c). In contrast, GG16-PERK-ko cells
showed only minor decrease in SOX2 levels.
The possible involvement of eIF2α in SOX2 down-
regulation was also investigated by using ISRIB, an inhi-
bitor known to reverse eIF2α phosphorylation31. ISRIB
potently reduced Tg-induced eIF2α-dependent activation
of ATF4 expression and also reduced CHOP levels,
however, did not affect Tg-dependent SOX2 down-
regulation (Fig. 6d). Since we already ruled out ATF4,
these results show that SOX2 expression is regulated
directly via PERK.
PERK regulates SOX2 expression and differentiation of
GBM neurospheres
ER stress has been reported to induce differentiation of
colon cancer stem cells32. To test if ER stress similarly
would induce differentiation in GBM neurospheres
mRNA levels of the astrocytic marker GFAP and the
neuronal markers OLIG2 and b3-Tubulin were deter-
mined in GG16 and GSC23 neurospheres exposed to Tg.
GFAP mRNA levels were hardly detectable by qRT-PCR
(not shown), whereas OLIG2 and b3-Tubulin levels
decreased, thus providing no evidence for Tg-induced
differentiation (Fig. 7a).
We also studied the effect of PERK knockout on serum-
induced differentiation of GG16 neurospheres. Interest-
ingly, absence of PERK resulted in impaired cell adhesion
compared with rapid adherence normally seen after
serum addition as observed by microscopy (Fig. 7b).
Moreover, western blots of serum-exposed GG16-PERK-
ko neurosphere cells demonstrated an impaired time-
dependent decrease in SOX2 expression in combination
with reduced accumulation of GFAP, which is normally
seen in serum-differentiated GG16 cells (Fig. 7c). Thus,
PERK also regulates SOX2 expression during serum-
induced differentiation and identiﬁes PERK as an impor-
tant mediator of GSC differentiation.
Discussion
In this study, using both primary GBM specimens and
GBM neurosphere models we examined the impact of ER
stress and the UPR on patient prognoses and GSC via-
bility and identiﬁed a novel role for PERK in GSCs self-
renewal and differentiation.
Table 2 Tg-induced cytotoxicity in GBM neurospheres
and differentiated (Diff.) counterparts measured by MTS
Tg [µM]
IC25 IC50 IC75
24 h 48 h 24 h 48 h 24 h 48 h
GG6 0.9 0.9 3.5 0.9 6.9 1.0
Diff.GG6 1 0.9 4 1.2 a 2.2
GG16 2.8 a 6.6 1.1 8.8 2.3
Diff.GG16 1.3 1 a 1.3 a 2.8
GG14 6.2 a 7.5 7.4 8.7 7.9
Diff.GG14 9.3 8.8 a a a a
GSC23 4.3 3.9 5.3 4.8 6.4 5.9
Diff.GSC23 6.9 7.6 a a a a
a>10 µM Tg
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Evaluation of UPR biomarker expression in primary GBM
samples on TMA revealed that high levels of ATF4 is
associated with poor prognosis in treatment naive patients.
This suggests that low activity of the PERK/eIF2α/ATF4
branch is beneﬁcial for prognosis. Our data are the ﬁrst
showing ATF4 protein expression in a large GBM patient
Fig. 4 PERK mediates Tg-induced cytotoxicity in GBM neurospheres/GSCs. a Western blots showing the effect of varying concentrations PERK
inhibitor GSK414 on PERK phosphorylation, BiP/GRP78, and CHOP expression in GG16 and GSC23 in absence or presence of Tg. Co-treatment with
1 µM GSK414 for 24 h showed potent PERK inhibition and reduction of CHOP. b GSK414 prevented Tg-induced ATF4 accumulation and caspase-3/
PARP cleavage. Co-treatment with Tg and GSK414 hardly altered ATF6 levels whereas XBP1 processing was increased. c MTS assays showing PERK
inhibition by GSK414 or d AMG44 suppressed Tg-induced cytotoxicity, whereas prolonged stimulation of PERK-eIF2α signaling by Guanabenz
(Guana) enhances cytotoxicity (e). Error bars indicate standard deviations. *p-value < 0.05
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dataset, and are in line with a recent report showing that
low ATF4 transcript levels in the NIH Rembrandt Glioma
database is associated with prolonged survival33. Although
we did not ﬁnd signiﬁcant associations between BiP/GRP78
or XBP1 expression in the GBM specimens and OS, cor-
relations were found between BiP/GRP78 and ATF4
Fig. 5 Tg reduces neurosphere formation capacity of GSCs that is associated with PERK-dependent downregulation of SOX2 expression. a
Limiting dilution assays of GG6 and GG14 Nsp cells treated for 24 h with Tg IC25 concentrations lead to a potent reduction of neurospheres formation
capacity. Treatment of GG16 and GSC23 Nsp with Tg IC25 and IC50 concentrations showed differential reduction of neurospheres formation capacity
in GG16 but not in GSC23. b Western blots demonstrating a strong reduction of SOX2 expression upon Tg treatment, whereas protein expression of
other GSC markers Oct4, Nestin, and Olig2 was not affected (c). d Western blots showing rescue of Tg-dependent reduction of SOX2 expression by
GSK414 co-treatment. e No rescue of SOX2 expression was seen by cotreating with the IRE1α inhibitor 4µ8c. Error bars indicate standard deviations.
*p-value < 0.05
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expression and between ATF4 and XBP1, suggesting asso-
ciations between ER stress and UPR activation. Others have
reported prognostic relevance of BiP/GRP78 and IRE1/
XBP1 in GBM, however, this was predominantly based on
mRNA levels34,35. Of note, ATF4 is activated via eIF2α, a
key player of the integrated stress response, able to respond
to various micro-environmental stresses such as hypoxia,
nutrient, glucose and amino acid shortage, involving a
number of upstream kinases including PERK36. Therefore
ATF4 accumulation is not solely the result of ER stress.
ATF4 has been implicated in promoting angiogenesis,
invasion and temozolomide resistance, which may explain
poor prognoses in high ATF4 expressing GBM patients37,38.
Our in vitro studies showed that particularly GBM
neurospheres were sensitive for Tg involving activation of
the PERK branch. Neurospheres belonging to the MES
subtype were more sensitive for Tg compared with PN
neurospheres. Overall, Tm-induced ER stress had similar
cytotoxic effects in these models, but differences between
PN and MES GBMs were less obvious. Notably, a link
between mesenchymal phenotype, increased UPR activity
and ER stress sensitivity has been reported in breast
cancer cells likely related to increased secretory activity39.
Regardless of the subtype, GBM neurospheres showed Tg
dose- and cell-dependent activation of all three UPR
branches known to orchestrate an adaptive survival
Fig. 6 PERK directly regulates ER stress induced SOX2 downregulation in GSCs. a BiP/GRP78, PERK, ATF4, CHOP, and SOX2 expression in GG16-
PERK or -ATF4 knockout (ko) cells treated with Tg, showing effective knockout of PERK and ATF4 and rescue of SOX2 downregulation in PERK-ko cells.
b RT-qPCR analyses was performed to determine the effect of 6 and 24 h IC50 Tg exposure on the expression of SOX2 GG16-PERK-ko. c Representative
IF images of SOX2 expression (green) in GG16 control and GG16-PERK-ko cells treated with(out) Tg for different times. Cells nuclei were stained with
DAPI (blue). SOX2 levels remain high in PERK-ko cells. d SOX2, ATF4, and CHOP protein expression in GG16 neurospheres after treatment with Tg in
absence/presence of eIF2α inhibitor ISRIB. Error bars indicate standard deviations. *p-value < 0.05
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response12,40. Cytotoxicity was accompanied by CHOP
accumulation, caspase-3/7 activation and PARP cleavage
indicative of apoptosis, which was corroborated by
decreased cytotoxicity upon co-administration with the
pan-caspase inhibitor Z-VAD. Interestingly, Tg also
induced necroptosis that could be inhibited by the RIPK1
inhibitor Nec-1. Necroptosis activation by ER stress has
not been frequently reported. Saveljeva et al.41 found that
Tm activates ligand-independent tumor necrosis factor
receptor 1 (TNFR1)-mediated necroptosis in murine
ﬁbroblasts and TNFR1/RIPK1 inhibition induced a switch
to apoptotic death. In the present study such a switch was
not seen and combined blocking of apoptosis and
necroptosis effectively suppressed Tg-induced cell death.
To mimic cellular heterogeneity in GBM, also serum-
differentiated neurospheres were examined. Differentiated
GBM cells appeared to be more resistant for Tg than
undifferentiated counterparts, which was linked with
reduced and altered UPR activation in a cell-dependent
manner. The underlying causes require more in depth
analysis. Regardless of that ER stress aggravation appears
particularly promising for eradicating the stem cell com-
partment of GBM. Transcriptomic analyses of UPR-
related genes provided mechanistic clues for differences in
Tg sensitivity between neurospheres and differentiated
cells. Neurospheres showed an overall increase in
expression of the main ER stress sensors, likely reﬂecting
higher UPR activity and a higher demand on protein
quality control in undifferentiated GBM cells. Among the
strongest upregulated genes were INSIG1 and MBTPS2
known to play a role in cholesterol metabolism and reg-
ulators of sterol regulatory element-binding proteins
(SREBPs) including ATF6, and ERAD. SIL1, encoding a
nucleotide exchange factor for BiP/GRP78 and NUCB1, a
calcium binding protein involved in maintaining calcium
homeostasis, were downregulated. Their precise rela-
tionship with ER stress sensitivity in neurospheres/GSCs
remains to be explored.
Fig. 7 PERK regulates SOX2 expression during serum-induced differentiation of GBM neurospheres/GSCs. a RT-qPCR analyses was performed
to determine the effect of 24 h IC50 Tg exposure on the expression of Olig2 and β3-Tubulin of GG16 cells. b Representative phase contrast
microscopy images (×10) of GG16 control and GG16-PERK-ko cells after 7 days serum exposure. c Protein expression of BiP/GRP78, PERK, SOX2, and
GFAP during serum differentiation of GG16-PERK-ko cells, showing aberrant differentiation in PERK-ko cells. Error bars indicate standard deviations.
*p-value < 0.05
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Importantly, the present study shows that ER stress
aggravation targets GSCs, considered key drivers of tumor
growth, aggressiveness and therapy resistance in
GBM1,7,8. ER stress induction by both Tg and Tm effec-
tively reduced neurosphere formation in limiting dilution
assays in three of the four GBM neurosphere models
tested, indicating that ER stress suppresses self-renewal
potential of GSCs. This is in accordance with the notion
that UPR activity is necessary for stem cell maintenance,
as was demonstrated for example in murine neural stem
cells16,42,43. Tg treatment of GSC/neurospheres did not
increase the expression of differentiation markers, which
is different to the situation in colon cancer stem cells
where ER stress induction has been reported to trigger
differentiation and sensitization for chemotherapy32.
We could associate loss of self-renewal capacity with a
speciﬁc strong decrease in SOX2 protein expression, a
well-known neural stem cell and GSC transcription fac-
tor28–30. This is in agreement with a recent study showing
that SOX2 expression is reduced upon exposure to Tm in
GBM neurospheres44. Interestingly, we found that PERK
directly regulates SOX2 downregulation at the protein
level, independent from eIF2α/ATF4 signaling, thus
identifying a novel noncanonical function for PERK.
SOX2 downregulation required the kinase function of
PERK, since GSK414 was sufﬁcient to prevent down-
regulation. Moreover, PERK-ko GBM neurospheres dis-
played aberrant serum-induced differentiation
characterized by failure to downregulate SOX2 and dis-
rupted upregulation of differentiation markers. This
indicates that other yet unknown signals or perhaps more
subtle alterations in protein-homeostasis associated with
differentiation may activate PERK. Our ﬁndings, sum-
marized in Fig. 8, add to the notion that PERK has
additional functions. For example, a UPR-independent
function for PERK has been reported by van Vliet et al.
involving direct interaction between PERK and Filamin A
and regulation of F-actin remodeling and calcium
homeostasis45. We have not been able to detect direct
SOX2-PERK protein interactions (not shown) and the
identiﬁed noncanonical mechanisms of PERK remains to
be further elucidated.
From a therapeutic standpoint we propose that ER
stress aggravation in GBM cells is beneﬁcial for patients
since it will result in depletion of the GSC compartment.
Although radiation and chemotherapy induce in part the
UPR, the development of clinical safe ER stress inducers
able to pass the blood-brain-barrier would be of great
interest. On the other hand, we predict that the use of
PERK inhibitors will potentially have great clinical value
since it will impair the plasticity of GSCs making them
less able to adapt to changes in the microenvironment and
toward therapy. However, this remains to be studied
further.
In conclusion, we found that the PERK pathway con-
tributes to ER stress-induced cytotoxicity in GBM neu-
rospheres and identiﬁed a noncanonical PERK-dependent
mechanism that regulates GSC self-renewal and differ-
entiation involving posttranscriptional regulation of
SOX2 expression via an as yet unknown mechanism. The
development of clinical applicable ER stress inducers and




Tissue samples of glioma grade IV diagnosed adult
patients without previous treatment or IDH mutations
were collected from November 2005 to January 2016 at
our institute for generating a TMA (4 cores per patient) as
described by Conroy et al.46. All experiments using
human tissue were conducted under the ‘Code of Con-
duct for dealing responsibly with human tissue in the
context of health research’ published by the Federation of
Dutch Medical Scientiﬁc Societies in 2011 (www.federa.
org) and approved by the local ethics review board on












PERK        SOX2
Fig. 8 Proposed model for regular and noncanonical PERK-
dependent signaling regulating ER stress cytotoxicity, self-
renewal, and differentiation in GBM. Summarizing ﬁgure depicting
the main ﬁndings of this study. The PERK branch of the UPR appears
to be a main inducer of apoptotic and necroptotic cell death in GSC/
neurospheres that suffer from ER stress-induced cytotoxicity. In
parallel, ER stress, also at lower levels, activates noncanonical PERK
signaling independent of the well-known downstream effectors eIF2α
and ATF4. This mechanism is able to downregulate protein levels of
the stem cell transcription factor SOX2 resulting in loss of stem cell
potential. Also more physiological conditions such as serum-induced
differentiation require noncanonical PERK signaling since genetic-
depletion of PERK resulted in aberrant differentiation characterized
with persistent SOX2 expression and impaired cell adherence. The
molecular link between PERK and SOX2 modulation remains to be
identiﬁed. See text for more details
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behalf of the medical ethical committee (METC) of the
UMCG (see Supplementary methods for more details).
Immunohistochemistry
Staining for BiP/GRP78, XBP1, and ATF4 was performed
according to standard protocols; positive and negative
controls, including immunoglobulin class-matched controls
(Diagnostics BV, Uithoorn, Netherlands) were used for each
staining. For detailed description of staining, scoring and
analysis (see Supplementary Methods and Supplementary
Table 2). Images were digitalized using the C9600
NanoZoomer (Hamamatsu Photonics KK, Almere,
Netherlands). Scoring of BiP/GRP78 and ATF4 was per-
formed automatically by using the positive pixel count
algorithm and software of Aperio Image Scope 12.3.3
(Leica Biosystems, Amsterdam, Netherlands). For eva-
luation of BiP/GRP78 and ATF4 staining the scores were
divided into two groups according to the median in low
and moderate-high expressing groups. XBP1 expression
was determined by scoring nuclear staining intensity and
percentage of positive cells by two independent observers
(NP and CM) blinded for patient outcome and random
samples were validated by a blinded expert pathologist
(WFAvD) XBP1 expression was scored according to the
immunoreactive score (IRS) that was divided into two
groups according to the median into low and moderate-
high staining groups. Overall survival (OS) was deﬁned as
the time between date of surgery and the documented
date of death. Shapiro–Wilk normalization indicated no
normal distributions of the staining, and therefore a
nonparametric statistical method was performed for
correlation analyses. Correlations between patients char-
acteristics and UPR biomarker co-expression were tested
using Spearman’s nonparametric correlation testing.
Survival curves were calculated with the Kaplan–Meier
method using the log-rank test after correction for age
over 70 years old that is a confounding factor for survival.
All tests were two-sided and a p-value of <0.05 was
considered signiﬁcant. Statistical analysis was performed
by using the statistical software SPSS 23.0 (IBM SPSS,
Armonk, New York, USA).
Cell culture
The GBM neurospheres used in this study have been
described before29,47 and were generated from surgical
leftovers obtained from anonymous GBM patients after
approval and following the ethical guidelines of the
Medical Ethics Review Committee (METC) of the Uni-
versity Medical Center Groningen (UMCG). The patient-
derived GBM neurospheres GG6, GG14, GG16, and
GSC23 were cultured in neural stem cell medium (NSM)
as previously described, GG6 and GG16 representing
MES GBM, GG14 and GSC23, PN GBM47. GBM neuro-
spheres were differentiated with 10% FCS culture
medium29. The GBM cell line GSC23 was kindly provided
by Krishna Bhat, PhD (Translational Molecular Pathology,
Department of Pathology, MD Anderson Cancer Center,
Texas University, USA). Cells were tested regularly by
SSTR proﬁling and for mycoplasma.
Cell viability and caspase activity assays
Cells were seeded in triplicate in 96-well plates at a cell
density of 1 × 104 cells/well and cultured for 24 h prior to
treatment with Tg (Sigma-Aldrich, Zwijndrecht, Nether-
lands) or Tm (Merck Millipore, Amsterdam, the Nether-
lands) at indicated concentrations and time periods. After
treatment, cell viability was determined using MTS assay by
incubation with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carbox-
ymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium solu-
tion according to manufacturer’s instructions (Promega
Corporation, Leiden, Netherlands). Cell viability was
determined by measuring the absorption at 492 nm on a
Microplate reader (BioRad, Veenendaal, Netherlands).
When indicated cells were (pre)treated with the following
chemicals: caspase inhibitor Z-VAD (Promega Corpora-
tion, Leiden, Netherlands), RIPK1 inhibitor necrostatin-1
and IRE1α inhibitor 4µ8c (Axon Medchem, Groningen,
Netherlands), PERK inhibitors GSK2606414 and AMG
PERK 44, GADD34 inhibitor Guanabenz acetate (Tocris
Bioscience, Bristol, UK and eIF2α inhibitor ISRIB (Sigma-
Aldrich, Zwijndrecht, Netherlands). Caspase-3/7 activities
were measured by using the Caspase-Glo 3/7 Caspase-
Glo® 3/7 Assay kit (Promega Corporation, Leiden, Neth-
erlands) following the manufacturer’s instructions. Cells
were seeded in triplicate on a white 96-well plate at a cell
density of 1 × 104 cells/well and pre-cultured for 24 h
before treatment with the ER stress inducing drugs at the
indicated drug concentrations for the given time period.
Western blotting
Western blotting was performed as described pre-
viously47. Standard treatment of cells was 24 h with Tg
IC50 concentrations unless otherwise stated. The mem-
branes were incubated overnight with the indicated pri-
mary antibody (see Supplementary Table 3). Quantiﬁed
bands are shown in Supplementary Fig. 6.
RNA isolation and qRT-PCR
Cells were treated as indicated and RNA was isolated
from cell pellets using TRIzol® Reagent (Life Technolo-
gies, Thermo Fisher Scientiﬁc, Bleiswijk, Netherlands)
following the manufacturer’s protocol. RNA quantiﬁca-
tion and cDNA synthesis for qRT-PCR was performed as
previously described46. Brieﬂy, qRT-PCR was performed
in triplicate using the iTaq SYBR Green Supermix with
Rox dye (BioRad, Veenendaal, Netherlands) in CFX384
TouchTM Real-Time PCR Detection System C1000
Thermocycler (BioRad, Veenendaal, Netherlands).
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Ampliﬁcation was performed with the following cycling
conditions: 5 min at 95 °C and 40 two-step cycles of 5 s at
95 °C and 30 s at 60 °C. Cycle threshold (Ct) values for
individual reactions were obtained using CFX Manager
Software (BioRad, Veenendaal, Netherlands). To deter-
mine relative gene expression levels, the CT values were
normalized to the house-keeping gene GAPDH using the
ΔCt method. Human primers used were previously
reported29.
mRNA sequencing and analyses
Illumina next-generation sequencing was performed
by the Genome Analysis Facility (GAF), Genomics
Coordination Centre (GCC) at University Medical
Centre Groningen (Groningen, Netherlands). Initial
quality check of and RNA quantiﬁcation of the samples
was performed by capillary electrophoresis using the
LabChip GX (PerkinElmer, Groningen, Netherlands).
Non-degraded RNA-samples were selected for sub-
sequent sequencing analysis. Sequence libraries were
generated using the TruSeq RNA sample preparation
kits (Illumina) using the Sciclone NGS Liquid Handler
(PerkinElmer, Groningen, Netherlands). In case of
contamination of adapter duplexes an extra puriﬁcation
of the libraries was performed with the automated
agarose gel separation system Labchip XT (PerkinElmer,
Groningen, Netherlands). The obtained cDNA fragment
libraries were sequenced on an Illumina HiSeq2500
using default parameters (single read 1 × 50 bp or
paired-end 2 × 100 bp) in pools of multiple samples.
Sequenced reads were trimmed and subsequently
aligned to build b37 human reference genome using
HISAT2 0.1.548 and SAMtools 1.249 allowing for two
mismatches. Gene level quantiﬁcation was done using
HTSeq/0.6.1p150 using --mode= union--stranded= no.
Ensembl v75 was used as reference for gene annotation.
Genes with <40 reads were kept out of the analysis.
Then reads counts were normalized using trimmed
mean of the M-values method. Differential expression
(DE) analysis between conditions was done using the
DESeq2 package51 for R (http://www.r-project.org/).
Each DE analysis was performed using paired samples
and including library size as covariate. Genes that had
an adjusted p-value ≤ 0.05, and a Log2 Fold Change
more or less than 1 were deﬁne as signiﬁcant differen-
tially expressed genes (DEG).
Limiting dilution assay
Cells untreated or treated as indicated were pelleted and
washed with PBS followed by Accutase (Sigma-Aldrich,
Zwijndrecht, Netherlands) treatment and careful repeated
pipetting in medium to dissociate cells. The single cell
suspension was sorted based on forward and side scatter
pattern using a ﬂow cytometer (BD Biosciences, Breda,
Netherlands). Single cells were seeded in 96-well plates at
a density of 10, 20, 40, or 80 cells/well in a volume of
100 μl NSM; cells were replenished with 50 μl of NSM
every 5–7 days. After 3 weeks, the number of neuro-
spheres per well was counted. Each condition was per-
formed in duplicate.
Generation of CRISPR/Cas9 knockouts
crRNAs were designed using https://benchling.com.
DNA oligonucleotides for PERK (EIF2AK3_guide_ex-
on_1_1_FWD CACCGAGACAGAGTTGCGACCGCG
and EIF2AK3_guide_exon_1_1_REV aaacCGCGGTCG-
CAACTCTGTCTC) and ATF4 (ATF4_exon_1_1_FWD
CACCGAGGTCTCTTAGATGATTACC and ATF4_ex-
on_1_1_REV aaacGGTAATCATCTAAGAGACCTC)
were ordered from IDT (Leuven, Belgium) and cloned
into pSpCas9(BB)-2A-GFP(PX458) (Addgene Tedding-
ton, UK), following the published protocol by Ann Ran
et al.52. After transformation in bacteria (One Shot™
TOP10 Chemically Competent E. coli; Thermo Fisher
Scientiﬁc, Bleiswijk, Netherlands), successful cloning was
validated by sequencing. GG16 cells were transfected
using FuGENE® HD Transfection Reagent (Promega
Corporation, Leiden, Netherlands) following manu-
facturer protocol. After 48 h cells were dissociated and
single cell sorting for GFP positivity in 96-well plates.
Cells were replenished with 50 μl of NSM twice weekly,
and after 3–4 weeks, neurospheres were passaged to a 48-
well plate for expansion. Effective ablation of PERK and
ATF4 was analyzed by western blotting. Representative
PERK and ATF4 knockouts (ko) were selected together
with control transfected GG16 cells for further use.
Immunoﬂuorescence
Cells on cytospins were ﬁxed with 3.7% formaldehyde-
PBS followed by permeabilization with 0.1% Triton-X
100-PBS. After blocking with 2% BSA/0.1% Tween20/
normal goat serum/PBS primary mouse anti SOX2 anti-
body (MAB2018, R&D Systems, Bristol, UK) and the
corresponding goat-anti-mouse secondary antibody
Alexa488 labeled (Life Technologies, Thermo Fisher Sci-
entiﬁc, Bleiswijk, Netherlands) were applied. DAPI was
used to counterstain nuclei and slides were mounted with
Glycerol/Gelatin solution. Fluorescent images of the
staining were visualized by ﬂuorescence microscopy
(Leica DM-6000 Microscope; Wetzlar, Germany) and
images of each condition were captured.
Statistical analysis
All experiments were performed for at least three times
independently unless otherwise stated. Statistical analysis
was performed using double sided, paired or unpaired
(depending on conditions) Student t-test. A p-value < 0.05
was considered signiﬁcant. Statistics used for IHC and
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RNA-seq analysis are described in the corresponding
section.
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